Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report

A high index of clinical suspicion of urinary tract infections due to empagliflozin use should be maintained in T2DM patients to avoid progression to life‐threatening condition.

Detalles Bibliográficos
Autores principales: Hazique, Mohammad, Surana, Arihant, Sinha, Mehul, Anand, Ayush
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811059/
https://www.ncbi.nlm.nih.gov/pubmed/36619486
http://dx.doi.org/10.1002/ccr3.6803
_version_ 1784863448452038656
author Hazique, Mohammad
Surana, Arihant
Sinha, Mehul
Anand, Ayush
author_facet Hazique, Mohammad
Surana, Arihant
Sinha, Mehul
Anand, Ayush
author_sort Hazique, Mohammad
collection PubMed
description A high index of clinical suspicion of urinary tract infections due to empagliflozin use should be maintained in T2DM patients to avoid progression to life‐threatening condition.
format Online
Article
Text
id pubmed-9811059
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98110592023-01-05 Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report Hazique, Mohammad Surana, Arihant Sinha, Mehul Anand, Ayush Clin Case Rep Case Report A high index of clinical suspicion of urinary tract infections due to empagliflozin use should be maintained in T2DM patients to avoid progression to life‐threatening condition. John Wiley and Sons Inc. 2023-01-03 /pmc/articles/PMC9811059/ /pubmed/36619486 http://dx.doi.org/10.1002/ccr3.6803 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Hazique, Mohammad
Surana, Arihant
Sinha, Mehul
Anand, Ayush
Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title_full Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title_fullStr Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title_full_unstemmed Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title_short Recurrent urinary tract infection associated with SGLT‐2 inhibitor in type 2 diabetes mellitus patient: A case report
title_sort recurrent urinary tract infection associated with sglt‐2 inhibitor in type 2 diabetes mellitus patient: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811059/
https://www.ncbi.nlm.nih.gov/pubmed/36619486
http://dx.doi.org/10.1002/ccr3.6803
work_keys_str_mv AT haziquemohammad recurrenturinarytractinfectionassociatedwithsglt2inhibitorintype2diabetesmellituspatientacasereport
AT suranaarihant recurrenturinarytractinfectionassociatedwithsglt2inhibitorintype2diabetesmellituspatientacasereport
AT sinhamehul recurrenturinarytractinfectionassociatedwithsglt2inhibitorintype2diabetesmellituspatientacasereport
AT anandayush recurrenturinarytractinfectionassociatedwithsglt2inhibitorintype2diabetesmellituspatientacasereport

Ejemplares similares